The effect of simvastatin in penile erection: a randomized, double-blind, placebo-controlled clinical trial (Simvastatin treatment for erectile dysfunction-STED TRIAL)

被引:14
作者
Mastalir, E. T. [1 ]
Carvalhal, G. F. [2 ]
Portal, V. L. [3 ]
机构
[1] Fundacao Univ Cardiol Rio Grande do Sul, Inst Cardiol Rio Grande do Sul, Urol Div Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil
[2] Fundacao Univ Cardiol, Inst Cardiol Rio Grande do Sul, Urol Div PUCRS, Porto Alegre, RS, Brazil
[3] Fundacao Univ Cardiol, Inst Cardiol Rio Grande do Sul, Div Cardiol, Porto Alegre, RS, Brazil
关键词
endothelial dysfunction; erectile dysfunction; C-reactive protein; simvastatin; vardenafil; CARDIOVASCULAR-DISEASE; CHOLESTEROL LEVELS; STATIN THERAPY; MEN; ATORVASTATIN; SILDENAFIL; DYSLIPIDEMIA; INHIBITORS; IMPOTENCE;
D O I
10.1038/ijir.2011.33
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study is to evaluate the effect of simvastatin in erectile dysfunction (ED) secondary to endothelial dysfunction. This study is a double-blind, randomized, placebo-controlled, clinical trial in patients with ED and endothelial dysfunction. Patients were randomized to receive 20 mg simvastatin (n = 21) or placebo (n = 20) daily for 6 months and subsequently 10 mg of vardenafil on demand for 4 weeks. Serum cholesterol, hormone profile, ultrasensitive C-reactive protein, the International Index of Erectile Dysfunction (IIEF) and the ED Index of Treatment Satisfaction were evaluated. There was a significant reduction in serum cholesterol in the treatment group. The hormonal profile remained unaltered. There was no difference in the IIEF between the groups at follow-up, although, at the beginning, 26% of the patients of both groups presented with mild ED and 74% with moderate-to-severe ED; at the end of the 7th month, all patients from the simvastatin group progressed to mild ED, compared with only 83% in the placebo group. There was no statistically significant difference in penile erection after intake of simvastatin or placebo. This study does not support the use of simvastatin as erectogenic medication. Further studies are necessary to verify if simvastatin has any beneficial effect on ED. International Journal of Impotence Research (2011) 23, 242-248; doi: 10.1038/ijir.2011.33; published online 30 June 2011
引用
收藏
页码:242 / 248
页数:7
相关论文
共 27 条
[1]   The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction [J].
Bank, Alan J. ;
Kelly, Aaron S. ;
Kaiser, Daniel R. ;
Crawford, William W. ;
Waxman, Benjamin ;
Schow, Douglas A. ;
Billups, Kevin L. .
VASCULAR MEDICINE, 2006, 11 (04) :251-257
[2]   Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction (vol 15, pg 231, 2003) [J].
Billups, KL ;
Kaiser, DR ;
Kelly, AS ;
Wetterling, RA ;
Tsai, MY ;
Hanson, N ;
Bank, AJ .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2003, 15 (05) :388-388
[3]   HMG CoA reductase inhibitors and impotence -: Two case series from the Spanish and French drug monitoring systems [J].
Carvajal, A ;
Macias, D ;
Sáinz, M ;
Ortega, S ;
Arias, LHM ;
Velasco, A ;
Bagheri, H ;
Lapeyre-Mestre, M ;
Montastruc, JL .
DRUG SAFETY, 2006, 29 (02) :143-149
[4]   Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms [J].
Castro, MM ;
Rizzi, E ;
Rascado, RR ;
Nagassaki, S ;
Bendhack, LM ;
Tanus-Santos, JE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 498 (1-3) :189-194
[5]   Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil [J].
Dadkhah, F. ;
Safarinejad, M. R. ;
Asgari, M. A. ;
Hosseini, S. Y. ;
Lashay, A. ;
Amini, E. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2010, 22 (01) :51-60
[6]  
*DEP ATH BRAZ SOC, 2007, ARQUIVOS BRASILEI S1, V88, P2
[7]   Statins and Erectile Dysfunction Results of a Case/Non-Case Study using the French Pharmacovigilance System Database [J].
Do, Catherine ;
Huyghe, Eric ;
Lapeyre-Mestre, Maryse ;
Montastruc, Jean Louis ;
Bagheri, Haleh .
DRUG SAFETY, 2009, 32 (07) :591-597
[8]   Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients [J].
Dobs, AS ;
Miller, S ;
Neri, G ;
Weiss, S ;
Tate, AC ;
Shapiro, DR ;
Musliner, TA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (01) :115-121
[9]   Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men [J].
Giugliano, F ;
Esposito, K ;
Di Palo, C ;
Ciotola, M ;
Giugliano, G ;
Marfella, R ;
D'Armiento, M ;
Giugliano, D .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2004, 27 (07) :665-669
[10]   Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction [J].
Gokkaya, Serkan Cevdet ;
Ozden, Cuneyt ;
Ozdal, Ozdem Levent ;
Koyuncu, Hasbey Hakan ;
Guzel, Ozer ;
Memis, Ali .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2008, 42 (05) :437-440